Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3247046
Max Phase: Preclinical
Molecular Formula: C17H21Cl2N3O4S2
Molecular Weight: 403.40
Molecule Type: Small molecule
Associated Items:
ID: ALA3247046
Max Phase: Preclinical
Molecular Formula: C17H21Cl2N3O4S2
Molecular Weight: 403.40
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCCCCOC(=S)SC(Cn1ccnc1)c1ccc(Cl)cc1Cl.O=[N+]([O-])O
Standard InChI: InChI=1S/C17H20Cl2N2OS2.HNO3/c1-2-3-4-9-22-17(23)24-16(11-21-8-7-20-12-21)14-6-5-13(18)10-15(14)19;2-1(3)4/h5-8,10,12,16H,2-4,9,11H2,1H3;(H,2,3,4)
Standard InChI Key: DIZBNZBUJQHJBN-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 403.40 | Molecular Weight (Monoisotopic): 402.0394 | AlogP: 6.16 | #Rotatable Bonds: 8 |
Polar Surface Area: 27.05 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 0 |
#RO5 Violations: 1 | HBA (Lipinski): 3 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: | CX Basic pKa: 6.50 | CX LogP: 6.57 | CX LogD: 6.53 |
Aromatic Rings: 2 | Heavy Atoms: 24 | QED Weighted: 0.39 | Np Likeness Score: -1.09 |
1. Walker KA, Hirschfeld DR, Marx M.. (1978) Antimycotic imidazoles. 2. Synthesis and antifungal properties of esters of 1-[2-hydroxy(mercapto)-2-phenylethyl]-1H-imidazoles., 21 (12): [PMID:722748] [10.1021/jm00210a037] |
Source(1):